Scott David Collins

Director, Non-clinical Development. at Mersana Therapeutics

Scott David Collins has a solid background in Pharmacology, with experience in companies such as Mersana Therapeutics, Novartis Institutes for BioMedical Research, and AstraZeneca. Currently serving as the Director of Non-Clinical Development at Mersana Therapeutics, Scott David Collins has held various roles in Pharmacology and Toxicology Biology throughout their career. Additionally, Scott David has experience in the academic sector as a Student Ambassador at the University of Manchester.

Links

Previous companies

AstraZeneca logo
The University of Manchester logo
Novartis logo

Timeline

  • Director, Non-clinical Development.

    October, 2022 - present

  • Associate Director, Pharmacology & Toxicology. Biology

    July, 2020

  • Senior Manager, Pharmacology & Toxicology. Biology

    January, 2018